Skip to main content

agilon health inc

For the period ended Nov 7, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 7, 2024 · Filed Nov 7, 2024

Use the contents to explore the available documents and sections.

AGL$113.39-0.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · In thousands, except per share data

In thousands, except per share data

September 30,2024December 31,2023
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents$148,161$107,570
Restricted cash and equivalents5,6296,759
Marketable securities244,766380,773
Receivables, net1,368,349942,461
Prepaid expenses and other current assets, net44,85442,513
Total current assets1,811,7591,480,076
Property and equipment, net28,19427,576
Intangible assets, net73,41263,769
Goodwill24,13324,133
Other assets153,913145,312
Total assets$2,091,411$1,740,866
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Medical claims and related payables$1,190,665$737,724
Accounts payable, accrued expenses and other218,492239,432
Total current liabilities1,409,157977,156
Long-term debt, net of current portion34,88432,308
Other liabilities72,49870,381
Total liabilities1,516,5391,079,845
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 411,960 and 406,387 shares issued and outstanding, respectively4,1204,064
Additional paid-in capital2,051,6381,986,899
Accumulated deficit(1,481,187)(1,326,826)
Accumulated other comprehensive income (loss)301(2,298)
Total agilon health, inc. stockholders' equity (deficit)574,872661,839
Noncontrolling interests—(818)
Total stockholders’ equity (deficit)574,872661,021
Total liabilities and stockholders’ equity (deficit)$2,091,411$1,740,866
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.